INIFY — INIFY Laboratories AB Balance Sheet
0.000.00%
Last trade - 00:00- NOK369.27m
- NOK310.37m
- SEK22.01m
Annual balance sheet for INIFY Laboratories AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Short Term Investments | 129 | 70.9 | 22.7 | 57.5 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 3.11 | 3.69 | 4.18 | 9.03 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Net Property, Plant And Equipment | 9.34 | 9.14 | 8.14 | 67.4 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Total Other Assets | ||||
| Total Assets | 152 | 93 | 42.9 | 141 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 13.8 | 7.95 | 9.5 | 33.1 |
| Common Stock | ||||
| Other Equity | ||||
| Total Equity | 138 | 85 | 33.4 | 107 |
| Total Liabilities & Shareholders' Equity | 152 | 93 | 42.9 | 141 |
| Total Common Shares Outstanding |